Dernières nouvelles pour Basel Medical Group (NASDAQ:BMGL) Stock

Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Key revenue is generated from Singapore.

Pony AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) shares advanced in Thursday&#8217;s premarket session following a major product development in <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/g46335554/pony-ai-inc-begins-mass-production-and-road-testing-of-multiple-gen-7-robotaxi-models" rel="noreferrer noopener">its autonomous vehicle efforts.</a>
The autonomous driving tech firm said its seventh-generation robotaxi platform has officially entered mass production and has started testing on public roads.
This marks a pivotal leap in the company&#8217;s journey to deploy a fleet of 1,000 autonomous vehicles by the end of 2025.
Also Read: <a href="https://www.benzinga.com/markets/tech/25/07/46269806/pony-ai-to-deploy-robotaxis-in-dubai-trials-begin-late-2025" target="_blank" rel="noreferrer noopener">Pony.ai To Deploy Robotaxis In Dubai, Trials Begin Late 2025</a>
The global robotaxi market, valued at $0.4 billion in 2023, is projected to soar to $45.7 billion by 2030, per a <a target="_blank" href="https://www.marketsandmarkets.com/Market-Reports/robo-taxi-market-132098403.html" rel="noreferrer noopener">report </a>from Markets And Markets, reflecting surging demand for autonomous mobility.
As the market accelerates, Pony AI is well-positioned to capitalize on this growth by scaling its Gen-7 fleet and expanding its global footprint in autonomous mobility solutions.
The company began production of the new-gen robotaxis in partnership with Guangzhou Automobile Group and Beijing Automotive Industry Corporation in June and July, respectively.
The company first introduced this Gen-7 autonomous system during the April Shanghai Auto Show. Following that, it swiftly moved into producing vehicles that incorporate its full-stack self-driving technology. Road testing is now underway in the Chinese cities of Guangzhou and Shenzhen.
This new generation of robotaxis is designed around three standout innovations: it&#8217;s the first to fully adopt automotive-grade components, slashes hardware costs by 70% compared to the previous version, and offers a modular design for rapid deployment across multiple car models.
With manufacturing now active, Pony AI is steering toward a commercially scalable rollout. The use of standardized components not only enhances safety and reliability but also sets the stage for wide adoption, supporting both private and public transport models.
Founded in 2016, Pony AI operates across China, East Asia, Europe, and the Middle East. The firm focuses on developing autonomous mobility solutions that are compatible with various vehicle types, using its proprietary Virtual Driver system.
This technology integrates software, hardware, and services to enable mass-scale, sustainable deployment of autonomous vehicles.
Price Action: PONY shares are trading higher by 1.65% to $12.34 premarket at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46289054/uber-is-going-to-get-eaten-alive-by-robotaxis-says-ross-gerber-as-autonomous-driving-gathers-steam" target="_blank" rel="noreferrer noopener">Uber Is Going To Get &#8216;Eaten Alive By Robotaxis,&#8217; Says Ross Gerber As Autonomous Driving Gathers Steam</a></li>
</ul>
Image via Shutterstock

Equities

News

Markets

Movers

Tech

General

PONY

Why Pony AI Stock Is Gaining On Thursday

MP: 49% &#x7C; <a href="https://www.benzinga.com/node/46338071">MP Materials Strikes Billion-dollar Deal With Pentagon to Build US Rare Earth Magnet Supply Chain</a>
&nbsp;
BTCM: 355% &#x7C; <a href="https://www.benzinga.com/node/46338088">BIT Mining Bets Big on Solana, Plans Up to $300M Investment to Build Long-Term Crypto Treasury</a>
&nbsp;
AIRI: 67% &#x7C; <a href="https://www.benzinga.com/node/46339202">Air Industries Group shares are trading higher after the company received a $5.4 million contract to supply landing gear steering collar components for US Air Force B-52 aircraft.</a>

Trading Ideas

AIRI

BTCM

Market-Moving News for July 10th

Venture capitalist Peter Thiel wielded significant influence over prominent tech leaders, including Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) CEO Mark Zuckerberg and Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk at critical junctures in their careers, according to a researcher tracking Founders Fund&#8216;s broader impact on Silicon Valley.
What Happened: Mario Gabriele, a venture capital researcher who spent 18 months studying Thiel and his investment firm, said during a Tuesday interview with Not Boring Radio that Thiel had &#8220;red-pilled&#8221; several influential tech figures who attended President Donald Trump&#8216;s January 20 inauguration.
&#8220;You can actually sort of really go through a lot of these powerful people and be like, &#8216;Wow, they are here at least in significant part because this person sort of red pilled them in a sort of key moment in their life,'&#8221; Gabriele said, referencing the Matrix film metaphor for awakening to uncomfortable truths.
Thiel&#8217;s influence network spans multiple tech powerhouses. His early $240,000 investment in PayPal Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) ultimately <a href="https://www.generalist.com/p/founders-fund-1">generated</a> $60 million in returns, establishing connections that proved strategically valuable. 
Founders Fund&#8217;s portfolio includes stakes in SpaceX, Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>), and Stripe, demonstrating Thiel&#8217;s ability to identify disruptive technologies early.
See Also: <a href="https://www.benzinga.com/news/25/07/46337678/chamath-palihapitiya-agrees-with-a-social-media-user-who-says-while-meta-spends-200-million-a-year-to-poach-ai-talent-elon-musk-keeps-costs-low-but-still-manages-to-unveil-better-products">Chamath Palihapitiya Agrees With A Social Media User Who Says While Meta Spends $200 Million A Year To Poach AI Talent, Elon Musk Keeps Costs Low But Still Manages To Unveil Better Products</a>
Gabriele reveals Thiel&#8217;s particularly decisive role in Vice President JD Vance&#8216;s trajectory. 
Thiel contributed $15 million to a super PAC supporting <a href="https://www.benzinga.com/startups/24/11/41865349/future-vice-president-jd-vance-has-a-powerful-silicon-valley-backer">Vance&#8217;s 2022 Ohio Senate campaign</a>, the largest single-candidate donation in Thiel&#8217;s history. Their relationship began in 2011 when Vance was a Yale Law student, leading to Vance&#8217;s eventual position at Thiel&#8217;s venture capital firm, Mithril Capital.
Why It Matters: Thiel&#8217;s influence extends beyond financial backing. Internal Meta emails from 2020 show Zuckerberg discussing demographic shifts with Thiel, leading to strategic pivots targeting younger audiences rather than baby boomers. &#8220;By the end of this decade, we expect more of these institutions to be run by and for the benefit of millennials and younger generations,&#8221; Zuckerberg wrote in <a href="https://www.benzinga.com/news/24/07/39663114/mark-zuckerberg-decided-to-shift-metas-focus-away-from-boomers-after-a-chat-with-palantirs-peter-thi">leaked internal communications</a>.
Thiel&#8217;s early angel investment in Facebook and his role in PayPal&#8217;s founding alongside Musk created lasting professional relationships. Despite tensions during PayPal&#8217;s tumultuous early years, including a 2000 boardroom coup that removed Musk as CEO, both executives maintained strategic ties to Thiel&#8217;s investment network.
Founders Fund has delivered exceptional returns across multiple vintages, with 2007, 2010, and 2011 funds generating gross multiples of 26.5x, 15.2x, and 15x, according <a href="https://www.generalist.com/p/founders-fund-1">to</a> Gabriele&#8217;s research. 
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="The Untold Story of Peter Thiel and Founders Fund (ft. Mario Gabriele)" width="500" height="281" src="https://www.youtube.com/embed/T8LDtRi-95E?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read Next: 
<ul class="wp-block-list">
<li><a href="https://benzinga.com/news/25/07/46288396/mark-cuban-says-his-children-struggle-with-the-downsides-of-his-wealth-not-that-they-want-to-be-poor" target="_blank" rel="noopener">Mark Cuban Says His Children Struggle With the Downsides of His Wealth: &#8216;Not That They Want To Be Poor, But It Sets An Expectation&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo Courtesy: Mark Reinstein On Shutterstock.com

Entrepreneurship

Success Stories

Startups

PLTR

PYPL

TSLA

Peter Thiel 'Red-Pilled' Elon Musk, Mark Zuckerberg And Silicon Valley's Elite At Critical Turning Points, Says Researcher Tracking Founders Fund's Influence

<a href="https://pr.report/c6p5">Arrive AI</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARAI#NASDAQ">ARAI</a>) - a pioneering autonomous delivery network anchored by Arrive Points&#x2122; - has selected <a href="https://pr.report/c6p6">Synoptek</a> as a strategic IT partner to enable its rapid growth and global ambitions. Synoptek will provide Arrive AI with all the IT solutions it needs to support its business.
With a recent injection of up to $40 million in funding from Streeterville Capital, Arrive AI is entering a critical growth phase. The company is preparing to launch its patented, autonomous delivery platform later this summer and expects to triple its staff size.
"Synoptek's strategic approach, deep expertise, robust tech stack and strong partnerships with Microsoft and ServiceNow made it a clear choice," said Mark Hamm, COO of Arrive AI. "We were searching for a partner who could move at our pace and help us build a resilient IT foundation for global expansion. After conducting an exhaustive search, we knew Synoptek would be the partner we were looking for to provide all of IT capabilities we need to take our business to the next level"
Under the three-year agreement, Synoptek will contribute to the solution definition, implementation and IT management, including, cybersecurity, enterprise-grade IT and 24/7 AI-enabled managed services operations. This engagement deepens Synoptek's presence in the high-growth logistics and manufacturing sector and aligns with its mission to deliver smart, secure and connected IT environments.

ARAI

Arrive AI Taps Synoptek to Power $40M Growth Push and Launch Autonomous Delivery Platform

Needham analyst Gerald Pascarelli maintains Celsius Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) with a Buy and raises the price target from $47 to $55.

Price Target

Analyst Ratings

CELH

Needham Maintains Buy on Celsius Holdings, Raises Price Target to $55

Ulta Beauty, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) today announced that it has acquired Space NK Limited, a leading British beauty retailer, from Manzanita Capital, a beauty sector specialist investor with a long-term investment horizon. Financial terms of the transaction were not disclosed.
The purchase of Space NK was funded with cash on hand and capacity under Ulta Beauty's existing credit facility. The acquisition is not expected to be material to Ulta Beauty's fiscal 2025 financial results and will not impact execution of its capital allocation priorities, including its share repurchase program.
 &nbsp;

ULTA

Ulta Beauty Acquires Space NK, Financial Terms Not Disclosed

Telsey Advisory Group analyst Joseph Feldman maintains Costco Wholesale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) with a Outperform and maintains $1100 price target.

COST

Telsey Advisory Group Maintains Outperform on Costco Wholesale, Maintains $1100 Price Target

Dividends

CLRO

On June 30, ClearOne Declared A One-time Special Stock Dividend To Provide Its Legacy Stockholders With A 100% Stake In The Proceeds From An Eventual Sale, The Board Of Directors Fixed July 11, 2025 As The Record Date For The Special Stock Dividend, And Will Be Payable On July 18, 2025

The wearable fitness device maker's stock has more than doubled in the last two weeks, as it looks set to return to revenue growth after three years of contraction
<h4 class="wp-block-heading">Key Takeaways:</h4>
<ul class="wp-block-list">
<li>Zepp Health's stock has more than doubled in the last two weeks, much of that in the last week, as it forecast 30% revenue growth in the second quarter, its first rise in three years</li>
<li>The company has been transitioning from making products under a licensing agreement with Xiaomi to developing its own Amazfit brand</li>
</ul>
Two weeks ago we brought you the <a href="https://www.benzinga.com/markets/equities/25/06/46093572/so-young-shares-get-a-makeover">story </a>of So-Young (SY.US), a cosmetic surgery clinic operator whose shares are up fivefold this year, most of that in the last month. Now, wearable fitness device maker Zepp Health Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZEPP#NYSE">ZEPP</a>) may be embarking on a similar ride as its shares have more than doubled in the last two weeks, much of that in the last week.
While it's possible both of these are simply GameStop-style meme stocks whose movements are the result of speculative buying without any financial foundation, it's also possible that something different is happening here. Put simply, we would postulate that this pair could represent a nascent renaissance for some of the many U.S.-listed Chinese companies whose shares have languished on Wall Street for the last five years.
So-Young seemed to catch investor attention with its move into direct operation of cosmetic surgery centers, away from its older business model of playing intermediary between independent centers and consumers. Zepp seems to have a similarly upbeat story to tell, including its imminent return to revenue growth for the first time since 2021.
Its rebirth comes as Zepp ditches its former business model of selling Xiaomi-branded wearables under a licensing agreement with the smartphone giant. In place of that, the company is developing its own brand, Amazfit, which is hugely challenging but also seems to finally be bearing fruit with Zepp's return to revenue growth.
More broadly speaking, these two stories of So-Young and Zepp could reflect a growing realization by investors that perhaps they have been too harsh on any and every U.S.-listed Chinese stock, and an acknowledgement that some companies might be worth a closer look. The chill in major new listings by Chinese companies in the U.S., which we've&nbsp;<a href="https://thebambooworks.com/hong-kong-ipos-explode-in-first-half-as-china-inc-abandons-new-york/">discussed previously</a>, could also be a factor. With few major new listings from China on the radar, investors may be starting to look at existing ones in search of some diamonds in the rough.
Even after its recent rally, Zepp's stock still only trades at a price-to-sales (P/S) ratio of 0.46, which is double where it was in March but still quite low.&nbsp;So-Young's&nbsp;P/S ratio was at a similar 0.42 at the end of March but has soared to 2.13 after its massive rally. Still, by comparison, both of those are well behind the 6.4 for global wearables giant&nbsp;Garmin&nbsp;(GRMN.US), showing there still could be some room for considerable upside.
Zepp has traveled down a difficult road since its U.S. listing in 2018. Back then it was known as Huami and its fate was closely linked to Xiaomi, a leading smartphone brand that also sells a wide range of other electronics, mostly under licensing agreements with other companies like Zepp. At the time of its IPO, about two-thirds of Zepp's sales came from Xiaomi products.
<h4 class="wp-block-heading">Ditching Xiaomi</h4>
But Zepp quickly discovered that its reliance on Xiaomi was limiting its ability to grow, and also generated far lower margins than companies with their own brands. It decided to change course, and made that switch official in 2021 when it changed its name from Huami to Zepp.
Its sales of Xiaomi products have dropped steadily since then, as its gross margin moved in the other direction, rising from about 25% in 2019 to 37.3% in the first quarter of 2024. Still, the latest figure is well below Garmin's 58%, which, again, shows there's still plenty of potential upside for Zepp if it can become a serious player in the global fitness tracker market.
That market is huge, worth about $61 billion last year, according to SNS Insider. What's more, sales are expected to grow around 15% annually between 2025 and 2032 to reach $230 billion yearly by the end of that period.
Zepp and its Amazfit brand are still just minnows in that market, but are quickly making a name for themselves as leaders in budget products often costing less than $100. As we noted earlier, the company's revenue has fallen sharply in recent years as it weaned itself from Xiaomi, shriveling from $614 million in 2022 to just $183 million last year.
But the steep declines have moderated in the last two quarters as the company separates itself from Xiaomi, which accounted for just 6% of its sales in the first quarter of this year. As that happened, it&nbsp;<a href="https://www.prnewswire.com/news-releases/zepp-health-corporation-reports-first-quarter-2025-unaudited-financial-results-302459680.html">reported</a>&nbsp;its first-quarter revenue fell by a relatively mild 3.6% to $38.5 million. But more importantly, it forecast revenue growth of around 30% in the second quarter, marking its first such year-on-year growth since 2021.
"We think the revenue growth trend will definitely go up for the remainder of the year," said CFO Leon Cheng Deng on the company's earnings call in May. "And you also noticed that our gross margin expansion journey has been growing, and we will continue that journey as well."
The company attributed the return to growth to two new products, the Amazfit Active 2 that went on sale during the quarter, and the Bip 6, which launched at the end of March. Both products have gotten generally positive reviews in the budget wearables category, and Zepp pointed out that each initially faced supply constraints that were expected to be fully resolved by the end of June.
Zepp was still losing money in the first quarter, reporting a $19.7 million net loss compared with a $14.8 million loss a year earlier.
The company talked up its growing geographic diversification, both in terms of sales and manufacturing. It said it currently sells its products in markets like the U.S., Spain and Italy. But it only specified that the U.S. accounts for about 15% of sales, which suggests the majority is still in China. In terms of manufacturing, it currently produces in China and Vietnam, the latter as a hedge against the U.S.-China trade war. It said it is also exploring the possibility of doing some manufacturing in the "NAFTA region," which probably refers to Mexico.
For now, at least, we'll need to sit back and watch if Zepp's shares follow in the footsteps of So-Young and continue their rally, which could signal renewed confidence in the company. Its operations certainly seem to be improving, though investors will probably want to see at least another quarter or two of solid growth and a return to profitability before giving it a longer-term thumbs up. &nbsp;&nbsp;

Sports

Opinion

ZEPP

Zepp Health's Stock Surge: A China Renaissance On Wall Street?

TNX-801 is up to 100,000-fold less virulent than live smallpox vaccine strains and a single dose provides robust immunogenicity&nbsp;and protection against mpox and rabbitpox (more than one year) in animals
Subcutaneous administration of TNX-801 yielded equivalent protection to the traditional percutaneous administration
CHATHAM, N.J., July 10, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNXP#NASDAQ">TNXP</a>), a fully integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced the presentation of new findings on TNX-801 (recombinant horsepox, live virus vaccine) at the Vaccine Congress 2025 in Vienna on July 10, 2025, by Sina Bavari, PhD, Executive Vice President, Infectious Disease Research and Development.
TNX-801 is a recombinant horsepox-derived vaccine candidate designed to prevent orthopox viruses and provide durable humoral and cellular immunity from a single dose. In primary human dermal cells, the virus replicates twenty-seven to one-hundred-nineteen-fold less than licensed vaccinia strains, and in interferon receptor knockout mice it is up to one-hundred-thousand-fold less virulent than those legacy vaccines. Preclinical studies further showed that a single dose of TNX-801 produced strong binding and neutralizing antibody responses across mice, rabbits, hamsters, and cynomolgus macaques, including immunocompromised animals. All vaccinated macaques survived lethal Clade I mpox challenge without lesions, and rabbit models remained fully protected for fourteen months.
The World Health Organization and the Centers for Disease Control and Prevention continue to classify mpox as an ongoing public-health concern. A single-dose vaccine with the attenuation and immunogenicity profile demonstrated by TNX-801 could streamline outbreak response by reducing the need for approved multi-visit immunization schedules.&nbsp;

TNXP

Tonix Pharma Presents New Findings On TNX-801, Recombinant Horsepox, Live Virus Vaccine, At Vaccine Congress 2025 In Vienna

Earnings

KALV

KalVista Pharmaceuticals FY25 EPS $(3.69)

Ant Group, the Chinese fintech powerhouse backed by Jack Ma, is reportedly planning to integrate Circle's USDC (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>) <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46321038/buckle-up-visa-stablecoins-process-800-billion-in-transactions-per-month-report-finds">stablecoin into its global blockchain platform</a>.
Quoting people familiar with the matter, Bloomberg <a href="https://www.bloomberg.com/news/articles/2025-07-10/jack-ma-backed-ant-to-add-circle-s-stablecoin-to-global-platform?embedded-checkout=true">reported</a> on Thursday that the move is contingent on USDC achieving full regulatory compliance in the United States.
Ant International, the overseas division of Ant Group, is spearheading the effort as part of its strategy to incorporate regulated digital currencies into its existing blockchain infrastructure. 
This platform currently supports functions like treasury management and cross-border payments and is increasingly positioning itself as a hub for tokenized financial instruments.
The discussions with Circle reflect a broader trend of growing institutional interest in regulated stablecoins following the passage of a U.S. Senate bill in June aimed at establishing a clear legal framework for dollar-backed digital assets. 
Circle, now a publicly traded company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>), has been one of the key beneficiaries of this policy shift. 
In April, it announced a new payments network to help financial institutions settle cross-border transactions using USDC.
While the exact timeline for the integration remains unclear, sources say Ant processed over $1 trillion in global payments last year, with one-third conducted via its blockchain. 
Also Read: <a href="https://www.benzinga.com/markets/25/07/46334404/xrp-eyes-2-40-as-ripples-rlusd-stablecoin-smashes-500m-market-cap">XRP Eyes $2.40 As Ripple&#8217;s RLUSD Stablecoin Smashes $500M Market Cap</a>
Ant International is also reportedly pursuing stablecoin licensing in Singapore, Hong Kong, and Luxembourg to support its expansion into regulated crypto offerings.
Stablecoins, digital tokens pegged to fiat currencies, are becoming essential infrastructure in global finance, with $250 billion in circulation as of June. 
However, regulators globally are still refining rules to prevent potential risks such as illicit use and sudden collapses.
Ant Group, whose record IPO was blocked in 2020 by Chinese regulators, has shifted focus from its once-dominant lending business toward blockchain and international growth. 
Ant International, now run with an independent board, posted nearly $3 billion in revenue in 2024 and is believed to have achieved two consecutive years of adjusted profitability. 
Analysts believe it could command a valuation of $8 billion to $24 billion if it pursues a listing in Hong Kong.
Both Circle and Ant declined to comment on the partnership.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/07/46333296/trump-medias-new-crypto-blue-chip-etf-filing-comes-with-a-twist">Trump Media&#8217;s New &#8216;Crypto Blue Chip ETF&#8217; Filing Comes With A Twist</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$USDC

CRCL

Circle Reportedly Integrating USDC With Jack Ma's Ant Group

Continuing to support the evolving needs of space system developers, Microchip Technology (NASDAQ:<a href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) has announced two new milestones for its <a href="https://www.microchip.com/en-us/products/fpgas-and-plds/radiation-tolerant-fpgas/rt-polarfire-fpgas">Radiation-Tolerant (RT) PolarFire&#xAE; technology</a>: MIL-STD-883 Class B and QML Class Q qualification of the RT PolarFire RTPF500ZT FPGA and availability of engineering samples for the RT PolarFire System-on-Chip (SoC) FPGA. These achievements underscore the company's more than 60 years of spaceflight heritage and its commitment to delivering highly reliable, low-power solutions for the most demanding space applications.
MIL-STD-883 Class B and Qualified Manufacturers List (QML) Class Q are industry standards that define rigorous testing and qualification processes for microelectronic components used in high-reliability applications, such as space and defense. MIL-STD-883, developed by the U.S. Department of Defense, outlines methods for environmental, mechanical and electrical testing to ensure device reliability under extreme conditions. QML Class Q, managed by the Defense Logistics Agency (DLA), certifies that manufacturers consistently produce components meeting these stringent requirements.&nbsp;
Unlike traditional SRAM-based FPGAs, RT PolarFire devices utilize nonvolatile technology, making them immune to configuration memory upsets caused by radiation. This eliminates the need for external mitigation measures, helping reduce system complexity and overall cost. RT PolarFire FPGAs consume up to 50% less power than mid-range SRAM-based alternatives, enabling satellite designers to optimize Size, Weight and Power (SWaP) without compromising mission-critical reliability. The PolarFire RTPF500ZT FPGA advances the family's capabilities, offering enhanced Single Event Latch-up (SEL) radiation performance and increased robustness for inflight programming compared to the original RTPF500T.

MCHP

Microchip Unveils Space-Ready Chips Built to Survive Extreme Conditions in Satellites and Defense Systems

ANNA

AleAnna Announces Early Performance From Longanesi Field; Says All Five Wells In The Phase 1 Development Are Contributing To Current Daily Production Averaging 28 Million Cubic Feet Per Day

FY 2026 Guidance
<ul>
<li>Continued revenue growth and strong profitability are expected for the first half of the fiscal year ending February 28, 2026, fueled by shipments from Sono-Tek's backlog, projected new and recurring orders, and ongoing strength in key markets such as medical devices. At May 31, 2025, equipment and service-related backlog totaled $7.5 million, providing a stable baseline of near-term demand. However, for the full fiscal year, we anticipate relatively flat revenue growth, reflecting a cautious outlook as the market adjusts to recent shifts in governmental clean energy and tariff policies, the full impact of which on customer demand and order timing remains unclear.</li>
</ul>

SOTK

Sono-Tek Projects Continued Revenue Growth And Strong Profitability For H1 FY26 Driven By Backlog And Market Demand

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fspire.com%2F&amp;esheet=54288470&amp;newsitemid=20250710827680&amp;lan=en-US&amp;anchor=Spire+Global%2C+Inc.&amp;index=1&amp;md5=a698a7428ff95e93740669b6403365a3">Spire Global, Inc.</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPIR#NYSE">SPIR</a>) ("Spire" or "the Company"), a global provider of space-based data, analytics and space services, announced the launch of Aircraft Exposure Analytics, an aviation solution that enables users to quantify aircraft-level exposure to hazardous weather conditions using real flight trajectories and global weather alerts.
Spire's Aircraft Exposure Analytics combines the Company's global multi-source ground and space-based Automatic Dependent Surveillance-Broadcast (ADS-B) flight data with Significant Meteorological Information (SIGMET) alerts to deliver environmental exposure metrics for each aircraft.
By overlaying flight paths with real-time and historical weather hazard data, Aircraft Exposure Analytics identifies when and where individual aircraft have flown through conditions such as turbulence, icing, thunderstorms, volcanic ash, tropical cyclones, and more. This insight provides airlines, maintenance teams, OEMs, lessors, and aviation insurers a clearer understanding of how environmental stressors may be affecting asset valuation, aircraft performance, safety, and long-term wear.

SPIR

Spire Launches Tool to Track Planes Flying Through Dangerous Weather Using Space-Based Data

Guidance

SMPL

Simply Good Foods Narrows FY2025 Sales Guidance from $1.444B-$1.471B to $1.444B-$1.457B vs $1.458B Est

Retail Sales

CORRECTION: Buckle June Comp-Store Sales Up 3.8%, Net Sales For 5-Week Fiscal Month Ended July 5, 2025 Up 4.7% Y/Y To $106.5M

WIIM

INMD

InMode shares are trading lower after the company cut its 2025 outlook.

InMode Sees Q2 Revenue $95.4M-$95.5M; Cuts 2025 Revenue Outlook From $395M-$405M To $365M-$375M

Press Releases

Basel Medical Group Ltd Announces Closing of US$8,820,000 Initial Public Offering

Basel Medical Group Ltd Announces Exercise of Overallotment Option

Basel Medical Group Signs Agreement to Acquire Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia

Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia

Basel Medical Group Ltd Kicks Off US$ 1.0 Billion Bitcoin (BTC) Acquisition Strategy Move

Basel Medical Group Subsidiary Awarded S$375 Million Contract to Supply Healthcare Products; Group to Enhance AI-Powered Healthcare Supply Chain Capabilities

Basel Medical Group Ltd Enters into US$ 1.0 Billion Bitcoin (BTC) Purchase Agreement

Basel Medical Group Ltd Reaffirms Strong Financial Position Amid Market Volatility

The CHIPS Act and Peraso Inc. (NASDAQ: PRSO): Advancing Semiconductor Innovation and National Security – More Stocks Inside

Basel Medical Obtains Waiver of Lock-Up for Potential Strategic Fund Raising

BLRX

BMGL

BSLK

PRSO

SNYR

TIRX

VIVK

AirSculpt Technologies, Inc. - Common Stock

AirSculpt Technologies

American Shared Hospital Services Common Stock

American Shared Hospital

Biodesix

Basel Medical Group Ltd - ordinary shares

Basel Medical Group

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International

Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares)

Comments

Basel Medical Group

Actualités

Dernières nouvelles pour Basel Medical Group (NASDAQ:BMGL) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL